Pharmacoeconomic review report: Fluocinolone acetonide intravitreal implant (Iluvien) (Knight Therapeutics Inc.)
Fluocinolone acetonide (FA) intravitreal implant (Iluvien), a corticosteroid, is indicated for the treatment of diabetic macular edema (DME) in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure. Iluvien i...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
October 2019, 2019
|
| Edition: | Version: final |
| Series: | CADTH common drug review
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references